Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Retatrutide , a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, showed up to 24.2% body weight reduction in Phase 2 trials
Gipr fl/fl within vehicle
Annals of the New York Academy of Sciences, 368-386, 1986
PlexusDx compounded semaglutide injection maintains a flat monthly price at $189/mo month-to-month, or from $149/mo on the 6-month plan regardless of dose escalation
By targeting additional pathways beyond GLP-1, retatrutide may provide more comprehensive appetite suppression and metabolic effects
Results Disclaimer: Individual results vary based on baseline health status, specific health goals, protocol adherence, and numerous other factors
US$ 27.36
US$ 29.09
US$ 20.17
US$ 22.01
